We are happy to announce our participation at 5th Inflammatory Skin Disease Summit (ISDS) being held in Vienna, Austria, at the “Aula der Wissenschaften” on November 15-18, 2023.
If you would like to schedule a personal meeting with Dr. Marta Bertolini (CEO of Monasterium Laboratory), please find a free slot here or send an email to Dr. Anasua Pal (email@example.com).
Our scientific contribution
Oral presentation – Abstract no. 27 – Saturday, November 18, 2023 – Morning lectures I – 8.00 am – 9.30 am
Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
Poster no. 90 – Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
Poster no. 132 – Exploring the role of interleukin 15 in atopic dermatitis: Lesson from a humanized mouse model > Abstract award-winning! DOWNLOAD the poster here.
Poster no. 133 – Short-term IL-23 neutralization reduces IL-23 transcription and number of activated pro-inflammatory mononuclear phagocyte (MNPs) in psoriasis skin ex vivo
Poster no. 170 – Perceived stress can trigger psoriatic lesions in human skin in vivo, which can be suppressed by aprepitant
Poster no. 185 – Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
Poster no. 261 – In-depth characterization of the inflammatory mechanisms underlying hidradenitis suppurativa (HS): Comparison of perilesional skin with nodules and tunnels
Poster no. 262 – Evidence of a role for IL-17F in the pathophysiology of dermal tunnels in hidradenitis suppurativa (HS): Implications for therapeutic interventions
Find more information about the summit on Inflammatory Skin Disease Summit 2023 (isds2023.org)
We are very much looking forward to seeing you all this November in Vienna, in the beautiful “Aula der Wissenschaften”!